Suchergebnisse - "Laharie, David"

PubPharm (18)

1

Time trend in surgical indications and outcomes in ulcerative colitis-A two decades in-depth retrospective analysis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Le Cosquer, G. | Capirchio, L. | Rivière, P. | +9

2

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Peyrin-Biroulet, L. | Rahier, J. | Kirchgesner, J. | +120

3

Efficacy and Safety of Infliximab Retreatment in Crohn's Disease : A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID

enthalten in: The American journal of gastroenterology | 2022

von Boschetti, G. | Nachury, M. | Laharie, D. | +18

4

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer

enthalten in: Gut microbes | 2022

von Lavelle, A. | Nancey, S. | Reimund, J. | +17

5

Altered sleep quality is associated with Crohn's disease activity : an actimetry study

enthalten in: Sleep & breathing = Schlaf & Atmung | 2020

von Bazin, T. | Micoulaud Franchi, J. | Terras, N. | +4

6

Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2020

von Martin, A. | Nachury, M. | Peyrin-Biroulet, L. | +62

7

Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent : a multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Hupé, M. | Rivière, P. | Nancey, S. | +11

CommentIn: Aliment Pharmacol Ther. 2020 Jun;51(11):1198-1199. - PMID 32424929

8

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Lair-Mehiri, L. | Stefanescu, C. | Vaysse, T. | +15

9

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Dulai, P. | Amiot, A. | Peyrin-Biroulet, L. | +95

CommentIn: Aliment Pharmacol Ther. 2020 Apr;51(7):738-739. - PMID 32162371

10

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease : A GETAID Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2019

von Caron, B. | Peyrin-Biroulet, L. | Pariente, B. | +21

CommentIn: J Crohns Colitis. 2019 Sep 27;13(10):1237-1238. - PMID 31560065